Tetraphase Pharmaceuticals Inc.

(TTPH) Trade

By |

Profile

Tetraphase Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It creates novel antibiotics for serious and life-threatening multidrug-resistant infections. Its pipeline products are ERAVACYCLINE, TP-271, and TP-6076.

Contact Information

Website: www.tphase.com
Main Phone: +1 617 715-3600
Address: 480 Arsenal Street
Address 2: Suite 110
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: NGS
CEO: Guy Macdonald
Employees: 78
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.92 $ -0.24 (-7.59%)
Last Price 2.92 Change $ -0.24 Change % -7.59 Tick N/A
Bid 2.90 Bid Size 900.00 Ask 3.09 Ask Size 12,000.00
Open 3.18 High 3.20 Low 2.91 Prev Close 3.16
Last Trade Volume 1.1 mi 52 Wk Hi 7.98 52 Wk Low 2.05
Market Cap 154.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,858,585.00 EPS (TTM) -1.63 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 10
Number of Buys 0 5
Number of Sells 0 5
Net Activity 0 -8876
Last 10 Buys Shares
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
Steven R. Gullans 1,000
L. Patrick Gage 1,000
Steven R. Gullans 1,000
Last 10 Sell Shares
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
John Thompson 1,000
Guy Macdonald 1,000
David Charles Lubner 1,000
Patrick Taylor Horn 1,000
L. Patrick Gage 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 6.43 6.43 6.43 6.43
Standard Deviation 2.15 2.15 2.15 2.15
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 5
Moderate Buy 1 1 1 1
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.63